AcuityMD is a commercial platform built for the medical technology industry. Thousands of sales and marketing professionals use AcuityMD to identify target markets, surface top opportunities, and grow their business.

• Branding, positioning and messaging
• Presentation design
• Web design & development
• Collateral, display graphics
• Social media & email 

Make the most of each opportunity and meeting that you get at LSI. Tighten your pitch deck storytelling and visuals. Elevate your social media presence. Make sure your message is simple to understand. See if www.alluviastudio.com can help you get there quickly and easily.

AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit ,www.alpha-sense.com.

Aptyx is a global medtech CDMO supporting a range of clinical markets, with particular expertise in complex interventional systems and transcatheter implants. Through Aptyx Interventional Systems, we partner with innovators from early-stage concept and feasibility through clinical, commercialization, and manufacturing at scale - bringing deep experience in covered stents and frames, catheter-based delivery systems, and integrated implant-delivery solutions.

Our teams work at the system level, aligning implant and delivery system design early to improve performance, reduce risk, and accelerate time to market. This approach is supported by the broader Aptyx network with seamless access to specialized capabilities including design & development.

With a collaborative, engineering-led mindset and a proven track record supporting both startups and global strategics, Aptyx helps emerging technologies move forward with greater speed, confidence, and scalability. Learn more at Aptyx.com or follow @Aptyx on LinkedIn.

Cedars-Sinai Intellectual Property Company helps turn ideas developed by our faculty into viable innovations. Its patent portfolio generates millions of dollars each year to support Cedars-Sinai’s basic and translational biomedical research efforts.

The Cedars-Sinai Accelerator assists growing healthcare startup companies in tailoring their solutions for maximum impact, with mentorship, funding and access to the resources, personnel and network of a world-class academic medical center.

Cedars-Sinai Health Ventures invests in the expansion of companies with viable products and services likely to be adopted by Cedars-Sinai.

CS Lifesciences are your one stop shop consultancy company based in the UK, Ireland and USA that can meet all your Quality, Clinical and Regulatory Needs.

Our knowledge and experience make us uniquely qualified to represent and support Manufacturers of Medical Devices, In Vitro Diagnostics (IVD) and Clinical Diagnostics.

End-to-End support, from development of your product, to establishing your quality management system, managing your clinical trials, regulatory submissions and post market support.  

We understand you have a business to run, and at CS Lifesciences we balance that with delivering your Quality, Clinical and Regulatory requirements. 

Whether navigating the FDA processes, obtaining CE marks or acting as your EU or UK Authorised Representative, CS Lifesciences will take you through the process in a way that minimizes time and resources – while meeting all your needs.

Our hands-on practical approach, is based on years of working with a vast range of different types and sizes of companies, meaning you get the best advice and clearly identified actions which lead to successful approval of your products.

CSSI is the nation’s premier engineering-based consulting firm specializing in tax law for Research & Development (R&D) Tax Credits helping businesses claim valuable tax credits for innovation, design, and prototype development.

CSSI also offers Cost Segregation Studies, Section 179D Energy Incentives, and Green Zip Tape Solutions - We partner with your tax professional delivering proven strategies to reduce tax liability and enhance sustainability.

With over 23 years of experience and 55,000+ studies completed, we help clients unlock tax savings, increase cash flow, and maximize financial benefits all without triggering audits.

Drummond Scientific Company, based near Philadelphia, is a leading life science manufacturing partner with over 75 years of proven expertise. Specializing in custom, high-throughput automated solutions, Drummond sets the industry standard for precision in diagnostic device manufacturing. Drummond is dedicated to advancing life science innovation by enabling faster, more scalable, and capital-efficient production. Through its venture manufacturing model, Drummond selectively invests in early-stage partners to bring breakthrough technologies to market—offering the infrastructure, expertise, and strategic support needed to accelerate commercialization.

Earlybird was founded in 1997 and we’ve been investing in healthcare since the beginning. Since 2016, Earlybird has had a fund focused specifically on healthcare: Earlybird Health. Our investment approach is broad and global and covers the entire spectrum of healthcare.

We have the experience, network, and capital to help innovative companies grow. Our typical ticket size is up to €15 million, invested over a company’s lifecycle.

We focus on highly differentiated technologies in attractive markets. Whether it's MedTech, Digital Health or Biopharma, we seek out companies that are truly innovating and pushing boundaries in healthcare.

Beyond capital, we bring deep industry knowledge, company-building expertise, and an extensive network that includes strategic partners – helping startups grow.

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.

Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.

As the medtech industry advances with renewed vigor, traditional capabilities are being outpaced by today’s rapid-fire market. To thrive, medtech companies must proactively transform their strategies around digitalization, innovation, supply chain, market capitalization, ESG, and much more. The EY Medtech team helps clients reimagine their end-to-end business ecosystem to enable both superior care delivery and sustained growth, shaping the future with confidence.

Greenberg Traurig (GT) is an international law firm with more than 3,000 attorneys across 51 offices worldwide. Our multidisciplinary team helps clients—from startups to global companies—navigate the complex legal and regulatory challenges that arise at the intersection of science, technology, and health care. We have deep knowledge of the frameworks governing the life sciences and health care sectors, including those set by the FDA and other governmental agencies, and extensive experience managing high-stakes litigation, from single claims to multidistrict matters and mass torts.

GT has a well-established record of developing robust global patent portfolios for medical device and digital health startups that can withstand the scrutiny of diligence and litigation, including some of the most disruptive technologies in MedTech over the last 15 years. In recent years, our team has served as counsel in several landmark transactions, including the #1 and #2 MedTech acquisitions of private companies in 2024, the #1 overall MedTech acquisitions in 2022 and 2024, and the largest MedTech acquisition in the history of Israel. By combining the firm’s collective experience in health care, intellectual property, regulatory, corporate, litigation, and governmental affairs, GT provides clients with innovative, informed, and practical legal strategies to support their business objectives—from discovery through product marketing and beyond.

IQVIA MedTech is a trusted global partner delivering integrated regulatory, clinical, quality and commercialization solutions to medical device and diagnostic companies. With former FDA and Notified Body reviewers, therapeutically aligned clinical teams and seasoned industry leaders, our team offers perspective on stakeholder expectations and clinical evidence strategies that align from the start. Bringing together regulatory insight, therapeutic specialization, industry expertise and high-quality data and technology, IQVIA MedTech meets the demands of the evolving MedTech industry, on a global scale with local precision. This integrated approach empowers MedTech innovators to accelerate development, navigate complexity and optimize performance to deliver impactful technologies to patients. To learn more, visit: iqviamedtech.com.

L.E.K. is an independent global strategy consultancy working closely with business leaders to seize competitive advantage and amplify growth. With a data-driven, insights-first approach, L.E.K. helps medtech and healthcare companies navigate complex industry landscapes, optimize commercial strategies, and accelerate innovation.

Legacy MedSearch is a retained executive search firm focused exclusively on medical device and MedTech innovation. Founded in 2005, we partner with early-stage, growth, and emerging commercial companies to secure leadership talent at critical inflection points—where strategy, execution, and clinical credibility must align.

Founded by an industry veteran with senior commercial experience inside Fortune 100 medical device organizations, including Johnson & Johnson and GE HealthCare, Legacy MedSearch is led by a senior recruiting team with exceptional tenure averaging 12.8 years with the firm, reflecting stability, continuity, and long-standing relationships across the medical device ecosystem.

With 12 total recognitions across Forbes’ Best Executive and Professional Recruiting Firm lists, Legacy MedSearch is known for its disciplined, research-driven approach. Our team brings deep domain expertise across surgical robotics, imaging and navigation, interventional technologies, and complex Class II/III devices.

Legacy MedSearch works closely with founders, boards, and investors as trusted advisors, supporting high-stakes leadership decisions in an increasingly competitive global medical device market.

With a presence in New York, Boston, San Francisco / Silicon Valley, Chicago, Charlotte, London, Geneva, Paris, Milan, and Tel-Aviv, LifeSci leverages its global relationships and local knowledge in multiple territories around the world to provide high-value services for clients. Our experienced team draws from diverse Wall Street, scientific, and communications backgrounds to successfully plan and implement strategic programs for public and private life sciences companies of all sizes and stages. We believe the composition of our five-person teams, the relationships we leverage, and services that we deliver to our clients are uniquely differentiated, and no other "IR" firm comes close to what we deliver.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. The organization is advancing a future in which the best possible care is available to everyone, including expanded care at home. Its relentless research leads to earlier diagnoses and new cures, inspiring hope for patients around the globe.

Mayo Clinic’s multidisciplinary experts collaborate to solve the most complex and unmet patient needs, driving innovations that power new technologies and transform how healthcare is delivered worldwide.

Medmarc is the leading expert in the products liability risks facing medical technology and life sciences companies.  Medical technology and life sciences companies are vulnerable to a variety of products liability risks that are unique to their industry. We understand these risks and specialize in providing insurance and risk management solutions designed to respond to the industry's particular needs.

MedtechWOMEN, is a nonprofit organization dedicated to advancing women leaders across the medical technology industry. Through high-impact events, thought leadership programs, and an engaged community, MedtechWOMEN brings together executives, innovators, and investors who are shaping the future of healthcare. Its flagship annual conference, MedtechVISION, along with regional networking events and leadership initiatives, fosters connection, visibility, and inspiration among women driving innovation in medtech.

Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world’s leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development life cycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services; NAMSA is the industry’s premier, trusted partner for successful development and commercialization outcomes.

We are NLC Health Ventures, a world-leading healthtech venture builder and early-stage investor. Our purpose is to bring science to life by bridging the gap between scientific discoveries and market-ready solutions that transform patients’ lives.

In the near future surgery will be incisionless.

We partner with Life Science startups and investors worldwide to accelerate and derisk transformational innovation on the path to clinical and commercial success. Whether your goals are focused on commercialization, IPOs, or strategic exits, we are here to help tailor our expertise to meet your specific needs. As highly experienced operators, we go beyond consultancy to bring a hands-on approach to every project. Our team's wealth of functional experience is dedicated to realizing your ideas and bringing them successfully to the market.

PRIA Healthcare is a leading full-spectrum reimbursement services and market access firm, instrumental in the successful commercialization of over 300 medical devices since 2012. As a trusted partner to innovators in MedTech and Life Sciences, PRIA delivers unparalleled expertise to navigate complex reimbursement landscapes.

Our experts in reimbursement strategy and healthcare economics outcomes research provide guidance to medical device companies by navigating challenging and uncertain reimbursement pathways, determining the coding, coverage, and payment for market access and adoption of new technologies. Our strategic approach accelerates the adoption of healthcare innovation, facilitating market access and appropriate reimbursement, today and into the future.

PRIA is specialty-agnostic, supporting the entire product journey from concept development to successful commercialization. For additional information please visit our website at www.PRIAHealthcare.com. 

Medtech organizations are undergoing unprecedented changes. Supply chain disruption, enhanced regulation, high healthcare costs, counterfeit products, cybersecurity issues and R&D challenges are just a few of the obstacles medical device manufacturers and suppliers face today. These market changes also bring opportunities to generate value and growth beyond historic industry norms.

Our team helps medtech companies streamline operations, develop innovative products, and deliver life-saving solutions to patients. 

RBrooks Group works exclusively in the Med-Tech industry to source, assess and place top talent in the United States and Europe. Roger Brooks and his team have over 80 years of combined experience assisting early stage and established medical device organizations identify and hire the best C-Suite, board member and vice president executives. We pride ourselves on our reputation and strive to be the most highly regarded executive search firm in the medical device industry

RQM+ is a global MedTech service provider focused on accelerating compliance and market success.

Through our unparalleled expertise and industry knowledge, we deliver specialized solutions and expedite the journey along the full product lifecycle for Med Device and IVD companies, from concept to commercialization to post-market.

Our portfolio of services enables the delivery of end-to-end solutions across the complete med device product lifecycle, with our:

✓ Regulatory and Quality Consulting

✓ Lab Services (Jordi Labs)

✓ Clinical Trials

✓ Reimbursement

✓ Technology Solutions

Santé invests at the forefront of Healthcare and Technology Innovation, managing over one billion in capital. Santé invests in innovative, early-stage healthcare companies across the Biotech, Medtech, and Healthtech industries.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.

Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.
The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is deeply established in Europe, with more than 50 years of experience backing over 500 companies and creating market leaders around the globe.

Today, Sofinnova Partners manages over €4 billion in assets.

Sonder Capital invests in teams and technologies that can transform healthcare in the medical
device, diagnostic, and healthtech sectors.

They are foundational investors, committing their energy and capital early to guide and support
companies from inception to acquisition or IPO. Core to their success is their ability and
willingness to be actively engaged with portfolio companies, partnering with entrepreneurs as
strategic advisors, providing more than just capital. 

Their insight into what it takes to bring innovative technologies to market stems from decades
of operating experience in the medtech industry. As founders, executives, and board members,
they have experienced and overcome many of the hurdles faced by entrepreneurs and
innovators.

Sterling Industries is a vertically integrated, North American based, contract manufacturer and assembler (CDMO) of medical devices and sub-components. We have deep experience manufacturing innovative medical devices across multiple specialties and technologies. Sterling has four facilities and broad capabilities including Class 7 Clean Rooms for product assembly and injection molding, and also has expertise with design and development of medical devices.

Sterling has extensive experience designing and manufacturing Medtech devices that include opto-electronics and micro-optics, medical hardgoods, OR and ICU equipment and devices, as well as single use sterilized products, with volumes ranging from the hundreds to the millions of units. We manage the entire process including the supply chain, manufacturing, assembly, testing, labeling, packaging, sterilization, and shipping.

Founded in 1992, The Mullings Group went all in on medtech, healthtech, and life sciences because we saw where the future was headed: people living longer, wanting to live healthier, and technology always seeking higher ground. Since then, we’ve completed over 9,000 successful placements across 900+ companies globally, with a search team that has over 100 years of combine tenure at TMG.

We deliver outcomes across three core areas: executive search, media & marketing, and advisory. Our consultative approach to search identifies and secures the right people at the right time, from individual contributors to C-suite and board roles, utilizing our proprietary tools and trademarked strategies aligned with your organization’s goals. Our advisory services support client-partners on organizational development, succession planning, and strategic initiatives that align people, story, and strategy.

As the only search firm in the world with a full media & marketing arm, we understand how critical it is to tell our clients’ stories at scale. Through Dragonfly, A TMG Company, our 9x award-winning media team develops hiring brands, thought leadership, and positioning strategies that attract talent, capital, and market attention.

With over 200,000 followers on LinkedIn, we’ve established ourselves as the trusted voice and partner in the industry.

Headquartered in Delray Beach, FL, with offices across the U.S., Canada, the UK, Israel, and APAC, we continue to expand alongside the companies driving innovation in medtech and emerging high-tech industries.

Who brings your message to market matters, and so does their reach. We have established ourselves as the “voice of the industry” in developing companies and careers. With over 175,000+ sets of eyes on us every day on career platforms like LinkedIn, where careers are built, we are the trusted partner in the industry.

TMG is headquartered in Delray Beach, FL, and has offices in the US, Canada, the UK, and APAC. As we continue to expand our search practices nationally and internationally, we continue to grow in medtech / life sciences and emerging high-tech industries.

TVM Capital Life Science (“TVM”) is a leading international venture capital firm focused on investing in life science innovations.  The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. 

TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. 

With its late-stage investments, TVM focuses on differentiated medical technologies with commercial proof-of-concept as well as late-stage therapeutics expected to quickly reach major development or regulatory milestones. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.  

The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.